IP Verse

Biomarin competitive analysis

Latest oppositions filed by Biomarin

Explore patent oppositions filed by Biomarin against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Aug 27, 2026
Patent NumberTitleApplicantOpposition Date
EP3516966
A Concentrated Krill Protein Hydrolysate FractionRIMFROSTAug 29, 2023
EP3311679
Method For Processing Crustaceans To Produce Low Fluoride/Low Trimethyl Amine Products ThereofRIMFROSTAug 24, 2022
EP2800481
Method For Processing Crustaceans To Produce Low Fluoride/Low Trimethyl Amine Products ThereofOLYMPIC SEAFOODOct 24, 2018
EP1782825
Treatment Of Glycogen Storage Diseases Type IiDUKE UNIVERSITYJun 8, 2015

Latest patents of Biomarin opposed by its competitors

Explore Biomarin's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Aug 27, 2026
Patent NumberPublication DateTitleTotal Oppositions
EP3328416
Mar 13, 2024Use Of C-Type Natriuretic Peptide Variants To Treat Skeletal Dysplasia3
EP3461503
May 11, 2022Methods Of Administering Tetrahydrobiopterin, Associated Compositions, And Methods Of Measuring5
EP3238737
Apr 6, 2022Means And Methods For Counteracting Muscle Disorders2
EP3138566
Jan 26, 2022Treatment Of Phenylketonuria With Bh43
EP2806900
Dec 15, 2021Rna Modulating Oligonucleotides With Improved Characteristics For The Treatment Of Duchenne And Becker Muscular Dystrophy2
EP3175863
Dec 1, 2021Variants Of C-Type Natriuretic Peptide2
EP2545939
Dec 16, 2020Methods Of Administering Tetrahydrobiopterin, Associated Compositions, And Methods Of Measuring5
EP2344637
Feb 28, 2018Methods And Means For Efficient Skipping Of Exon 45 In Duchenne Muscular Dystrophy Pre-Mrna1
EP1708690
Jul 20, 2016Treatment Of Phenylketonurias With Bh43
EP2607484
Jan 6, 2016Methods And Means For Efficient Skipping Of Exon 45 In Duchenne Muscular Dystrophy Pre-Mrna1

Latest PTAB cases involving Biomarin

Discover the latest PTAB cases involving Biomarin, highlighting their recent legal challenges and patent disputes.

Last updated on: Aug 30, 2026
Proceeding NumberFiling DatePetitionerRespondentStatus

Get alerts for PTAB Cases involving Biomarin

PGR2026-00055Jun 5, 2026ZYDUS LIFESCIENCESBIOMARIN PHARMACEUTICALPending
PGR2026-00013Nov 24, 2025ASCENDIS PHARMABIOMARIN PHARMACEUTICALTrial Instituted
IPR2013-00534Aug 28, 2013BIOMARIN PHARMACEUTICALGENZYME THERAPEUTIC PRODUCTS PARTNERSHIPFinal Written Decision
IPR2013-00535Aug 28, 2013BIOMARIN PHARMACEUTICALDUKE UNIVERSITYFinal Written Decision
IPR2013-00537Aug 28, 2013BIOMARIN PHARMACEUTICALGENZYME THERAPEUTIC PRODUCTS PARTNERSHIPFinal Written Decision

Peer Comparison New

IP litigation analysis comparing Biomarin with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Aug 27, 2026
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
AKER BIOMARINE ANTARCTIC34 - 12
OLYMPIC SEAFOOD - 1 - -
RIMFROST4712 -